Gambro acquires clinics in Lithuania

June 02, 2006

Gambro Healthcare announced today that it has started operations in Lithuania by acquiring 11 clinics with about 300 patients. Gambro Healthcare will through this major acquisition broaden its market presence and take a further step into the Baltic States, an important emerging market.

“I am very happy with this acquisition, which from the start gives us a strong presence in the Lithuanian market. It is an important strategic move, in line with our growth ambitions and is also a step to strengthen Gambro’s overall position in emerging markets,” says Bo-Inge Hansson, President Gambro Healthcare.

The Lithuanian dialysis services market comprises of approximately 1, 200 patients, whereof half are treated in the private sector and the remainder in public hospitals. The market shows a lower prevalence of patients with chronic kidney disease than many other markets in Europe and is therefore expected to show a good growth.

The clinics will be consolidated from June 1, 2006. The acquisition is expected to have a limited financial impact on a Gambro group level but is important from a strategic point of view.

Gambro Healthcare is one of the world’s leading provider of renal care services, and offer a full range of end-stage renal disease treatment and patient care. With this acquisition Gambro Healthcare now operates in 15 countries and treats some 12 000 patients in about 160 clinics.

For further information please contact: Paula Treutiger, Vice President, Corporate Communications, tel. +46-8-613 65 99, +46-73-366 65 99 Sophie Monsén, Manager, Investor Relations, Corporate Finance, tel. +46-8-613 65 02, +46-73-366 65 02 Kevin Smith, President Gambro Inc., Investor Relations US, tel. +1-303 231 4750 Annika Wolder, Manager Internal Communications, Gambro Healthcare, tel. +46-46-16 91 12, +46 734-16 91 12

Gambro is a global medical technology company with related services and has leading positions in renal care - services and products - and blood component technology. Gambro Renal Products develops and supplies hemodialysis, peritoneal dialysis, and acute renal and liver dialysis products, therapies and services. Gambro Healthcare is a provider of end-stage renal disease treatment and patient care. Gambro BCT develops and provides blood collection, apheresis and cell therapy products and services.

Contact Information

Paula Treutiger

Vice President, Corporate Communications

Gambro Inc.

Contact via E-mail